Nelson Stone

8PUBLICATIONS
3CO-AUTHORS
Medical physicsRadiation therapyPredictive and prognostic markersAccelerators
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 17, 2025
Method to determine the nadir PSA following partial gland ablation.

Nelson N Stone, Vassilios Skouteris, Rendi Shu

|Oct 28, 2022
Editorial Comment to Local dose (biological effective dose <180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low-dose-rate brachytherapy.

Nelson N Stone

|Apr 27, 2022
Transperineal prostate biopsy identifies locations of clinically significant prostate cancer in men considering focal therapy with PI-RADS 3-5 regions of interest.

Nelson Stone, Vassilios Skouteris, Samuel Chang

|Jun 30, 2018
Stage T3b prostate cancer diagnosed by seminal vesicle biopsy and treated with neoadjuvant hormone therapy, permanent brachytherapy and external beam radiotherapy.

Nelson N Stone, Richard G Stock

|May 05, 2018
Factors influencing long-term urinary symptoms after prostate brachytherapy.

Nelson N Stone, Jared S Winoker, Steven A Kaplan

|Jan 11, 2018
Low-dose-rate brachytherapy for prostate cancer: outcomes at >10 years of follow-up.

Stanislav Lazarev, Marcher R Thompson, Nelson N Stone

Pageof 2

Frequent Collaborators

5 joint publications

Richard G Stock

1 joint publications

Stanislav Lazarev

1 joint publications

Ben Gl Vanneste